George Clinical’s success with demanding oncology trials has established an award-winning reputation as the leading CRO of choice for conducting a wide variety of oncology studies. George Clinical combines scientific and clinical leadership with expert trial delivery to create distinctive solutions for all phases, registration and post-marketing trials. To learn more about our world-class experience, global capabilities and expert scientific leadership, please click the links below.
George Clinical has extensive experience in all phases of oncology programs including, MTD, early phase I, II and III, late-phase trials, health economics and outcomes research and have conducted more than 400 oncology studies.
Founded in Asia-Pacific and driven by scientific expertise and operational excellence, George Clinical is a leading, global clinical research organization with over 20 years of experience.
Our experienced CGT team delivers studies based on early risk management plans, scientific integrity, the highest ethical standards and maximum quality assurance.
With our immense experience in clinical trial and post-marketing surveillance, we provide the latest safety and pharmacovigilance services, keeping abreast of global safety regulations.
Learn more about how our team brings unique expertise to Oncology clinical trials.
